These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Trends in Out-of-Pocket Costs for and Characteristics of Pharmacy-Dispensed Buprenorphine Medications for Opioid Use Disorder Treatment by Type of Payer, 2015 to 2020. Strahan AE, Desai S, Zhang K, Guy GP. JAMA Netw Open; 2023 Feb 01; 6(2):e2254590. PubMed ID: 36763363 [Abstract] [Full Text] [Related]
7. Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic. Tilhou AS, Dague L, Saloner B, Beemon D, Burns M. JAMA Health Forum; 2022 Mar 01; 3(3):e220093. PubMed ID: 35977284 [Abstract] [Full Text] [Related]
14. Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA. Zang X, Walley AY, Chatterjee A, Kimmel SD, Morgan JR, Murphy SM, Linas BP, Nolen S, Reilly B, Urquhart C, Schackman BR, Marshall BDL. Addiction; 2023 Dec 01; 118(12):2413-2423. PubMed ID: 37640687 [Abstract] [Full Text] [Related]
15. Changes in Racial and Ethnic Disparities in Access to Care and Health Among US Adults at Age 65 Years. Wallace J, Jiang K, Goldsmith-Pinkham P, Song Z. JAMA Intern Med; 2021 Sep 01; 181(9):1207-1215. PubMed ID: 34309621 [Abstract] [Full Text] [Related]
19. Mediation of Racial and Ethnic Inequities in the Diagnosis of Advanced-Stage Cervical Cancer by Insurance Status. Holt HK, Peterson CE, MacLaughlan David S, Abdelaziz A, Sawaya GF, Guadamuz JS, Calip GS. JAMA Netw Open; 2023 Mar 01; 6(3):e232985. PubMed ID: 36897588 [Abstract] [Full Text] [Related]